We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Cato Corp
CATO
$68.7M
| $1.08M | 0.01% |
64,271
-19,598
| -23% | -$290K |
|
727
OneWater Marine
ONEW
$221M
| $1.08M | 0.01% |
25,620
-25,180
| -50% | -$1.17M |
|
|
GSKY
728
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $1.08M | 0.01% |
+193,937
| New | +$1.16M |
|
729
Lee Enterprises
LEE
$165M
| $1.07M | 0.01% |
37,829
-3,469
| -8% | -$102K |
|
730
PJT Partners
PJT
$4.5B
| $1.07M | 0.01% |
14,949
-70,526
| -83% | -$5.03M |
|
731
American Coastal Insurance
ACIC
$505M
| $1.07M | 0.01% |
186,992
+94,272
| +102% | +$577K |
|
732
Camden National
CAC
$939M
| $1.06M | 0.01% |
22,270
+9,893
| +80% | +$470K |
|
733
Inogen
INGN
$169M
| $1.06M | 0.01% |
+16,250
| New | +$1.03M |
|
|
THS
734
DELISTED
Treehouse Foods
THS
| $1.04M | 0.01% |
23,449
| – | – |
|
735
Red Robin
RRGB
$139M
| $1.03M | 0.01% |
+31,144
| New | +$1.06M |
|
736
Old Republic International
ORI
$10.5B
| $1.02M | 0.01% |
41,091
| – | – |
|
|
RVLP
737
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $1.02M | 0.01% |
339,129
-69,489
| -17% | -$213K |
|
738
Capital City Bank Group
CCBG
$890M
| $1M | 0.01% |
38,851
+886
| +2% | +$23K |
|
739
Trinity Industries
TRN
$2.97B
| $1M | 0.01% |
+37,255
| New | +$1.05M |
|
740
Cytokinetics
CYTK
$11.1B
| $1M | 0.01% |
+50,570
| New | +$1.19M |
|
|
SQZ
741
DELISTED
SQZ Biotechnologies Company
SQZ
| $1M | 0.01% |
69,189
+45,159
| +188% | +$590K |
|
|
MNTV
742
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $984K | 0.01% |
46,720
| – | – |
|
|
RPT
743
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $977K | 0.01% |
75,258
-30,062
| -29% | -$382K |
|
|
NH
744
DELISTED
NantHealth, Inc
NH
| $968K | 0.01% |
27,825
+26,166
| +1,577% | +$1.04M |
|
|
HZN
745
DELISTED
Horizon Global Corporation
HZN
| $964K | 0.01% |
113,635
+15,752
| +16% | +$137K |
|
|
GTS
746
DELISTED
Triple-S Management Corporation
GTS
| $962K | 0.01% |
43,189
+4,603
| +12% | +$114K |
|
747
Primis Financial Corp
FRST
$388M
| $955K | 0.01% |
62,567
+26,645
| +74% | +$400K |
|
748
First Internet Bancorp
INBK
$236M
| $950K | 0.01% |
30,650
+7,406
| +32% | +$251K |
|
749
IDT Corp
IDT
$1.62B
| $949K | 0.01% |
25,666
| – | – |
|
750
Orion
OEC
$400M
| $945K | 0.01% |
49,750
+27,873
| +127% | +$551K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.